GForce Life Sciences’ Post
More Relevant Posts
-
October is Breast Cancer Awareness Month. This month, we unite to raise awareness, offer support, and honor individuals and families impacted by breast cancer. Early detection saves lives, so let's encourage regular screenings, spread knowledge and foster a community of support. Together, we can make a difference! Whether you're wearing pink, sharing resources, or supporting research, every effort counts!
To view or add a comment, sign in
-
New AI tools are finding new uses for old drugs, particularly rare disease. This can provide a more cost-effective way to develop new therapies than designing new drugs from scratch. Give it a read!
To view or add a comment, sign in
-
GForce Success Story! Follow us for more success stories and visit out website at www.gforcelifesciences.com
To view or add a comment, sign in
-
This week for #FeatureFriday we're thrilled to highlight Lydia Shook, one of our recruiters! Her passion for finding the perfect match doesn't go unnoticed. Lydia brings expertise, energy, and an unwavering commitment to her candidates. Her ability to connect with people and deliver exceptional results makes her an invaluable asset to our team. Thank you, Lydia, for all your hard work and dedication - you truly make a difference!
To view or add a comment, sign in
-
An antibody-drug conjugate developed by Daiichi Sankyo and Merck met the main goal of a Phase 3 lung cancer trial. Daiichi, which discovered one of the most success drugs in the breast cancer market has paired with Merck to develop this antibody-drug even more. Give it a read!
ADC developed by Daiichi, Merck outperforms chemo in lung cancer trial
biopharmadive.com
To view or add a comment, sign in
158,167 followers